Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: preliminary results from a phase II trial (Q40531858)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 2004
edit
Language Label Description Also known as
English
Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: preliminary results from a phase II trial
scientific article published on April 2004

    Statements

    Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: preliminary results from a phase II trial (English)
    Amadeu Pelegrí
    José I Mayordomo
    Jesús Florián
    Santiago Vázquez
    Marta Martn-Richard
    Javier Virizuela
    Antonio Antón
    Spanish Group for Breast Cancer Research (GEICAM)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit